Research looked at all admissions for five to 18-year-olds to general acute medical wards in England from 2012 to 2022.
MDMA, psilocybin, ketamine derivatives, and other hallucinogens are authorised in certain countries to treat depression or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback